Treatment‐related adverse events of antibody‐drug conjugates in clinical trials: A systematic review and meta‐analysisJinming Li, Jiuda Zhao, Guoshuang Shen et al.|Cancer Innovation|2023Cited by 15
Watson for oncology decision system for treatment consistency study in breast cancerYaobang Liu, Xinlan Liu, Guoshuang Shen et al.|Clinical and Experimental Medicine|2022Cited by 13
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 PatientsQin Ma, Xinlan Liu, Yaobang Liu et al.|Breast Cancer Targets and Therapy|2024Cited by 10
Survival nomogram for patients with de novo metastatic breast cancer based on the SEER database and an external validation cohortLizhi Ning, Xinlan Liu, Yaobang Liu et al.|Cancer Pathogenesis and Therapy|2023Cited by 7
Clinicopathological characteristics and prognostic factors in invasive micropapillary carcinoma of the breastYaobang Liu, Xinlan Liu, Xu-Tong Gao et al.|Archives of Medical Science|2024Cited by 6